The mutant TET2 contributes to AITL oncogenesis by not only increasing self-renewal capacity of hematopoietic stem/progenitor cells but up-regulating BCL-6 that alters TFH differentiation [14]. This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.